Literature DB >> 11237064

Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssion.

M D Tabernero1, A M Bortoluci, I Alaejos, M C López-Berges, A Rasillo, R García-Sanz, M García, J M Sayagués, M González, G Mateo, J F San Miguel, A Orfao.   

Abstract

The Philadelphia chromosome (Ph+) reflects a balanced reciprocal translocation between the long arms of chromosomes 9 and 22 [t(9;22)(q34;q11.2] involving the BCR and ABL genes. At present, detection of BCR/ABL gene rearrangements is mandatory in precursor-B-ALL patients at diagnosis for prognostic stratification and treatment decision. In spite of the clinical impact, no screening method, displaying a high sensitive and specificity, is available for the identification of BCR/ABL+ precursor-B-ALL cases. The aim of the present study was to explore the immunophenotypic characteristics of precursor B-ALL cases displaying BCR/ABL gene rearrangements using multiple stainings analyzed by quantitative flow cytometry in order to rapidly (<1 h) identify unique phenotypes associated with this translocation. From the 82 precursor-B-ALL cases included in the study 12 displayed BCR/ABL gene rearragements, all corresponding to adult patients, four of which also displayed DNA aneuploidy. Our results show that BCR/ABL+ precursor B-ALL cases constantly displayed a homogeneous expression of CD10 and CD34 but low and relatively heterogeneous CD38 expression, together with an aberrant reactivity for CD13. In contrast, this unique phenotype was only detected in three out of 70 BCR/ABL cases. Therefore, the combined use of staining patterns for CD34, CD38 and CD13 expression within CD10-positive blast cells is highly suggestive of BCR/ABL gene rearrangements in adults with precursor B-ALL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237064     DOI: 10.1038/sj.leu.2402060

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  13 in total

1.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

Review 2.  Primary testicular Ph-positive B lymphoblastic lymphoma: an unusual presentation and review.

Authors:  Jiling Zhu; Shiying Zhang; Li Zhu; Xinlu Li; Ying Wang; Yaqi Duan; Wei Huang
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

3.  Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors.

Authors:  Jesse Jaso; Deborah A Thomas; Krista Cunningham; Jeffrey L Jorgensen; Hagop M Kantarjian; L Jeffrey Medeiros; Sa A Wang
Journal:  Cancer       Date:  2011-03-01       Impact factor: 6.860

4.  Immunophenotypes and outcome of Philadelphia chromosome-positive and -negative Thai adult acute lymphoblastic leukemia.

Authors:  Chirayu Udomsakdi-Auewarakul; Orathai Promsuwicha; Chintana Tocharoentanaphol; Chanya Munhketvit; Kovit Pattanapanyasat; Surapol Issaragrisil
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

5.  Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhood acute lymphoblastic leukemia.

Authors:  Kerrie Wilson; Marian Case; Lynne Minto; Simon Bailey; Nick Bown; Jenny Jesson; Sarah Lawson; Josef Vormoor; Julie Irving
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

6.  A unique complex translocation involving six different chromosomes in a case of childhood acute lymphoblastic leukemia with the Philadelphia chromosome and adverse prognosis.

Authors:  Walid Al Achkar; Abdulsamad Wafa; Hasmik Mkrtchyan; Faten Moassass; Thomas Liehr
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

7.  Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial.

Authors:  Josep-Maria Ribera; Albert Oriol; Marcos González; Belén Vidriales; Salut Brunet; Jordi Esteve; Eloy Del Potro; Concepción Rivas; Maria-José Moreno; Mar Tormo; Victoria Martín-Reina; Josep Sarrá; Ricardo Parody; Jaime Pérez de Oteyza; Encarna Bureo; Maria-Teresa Bernal
Journal:  Haematologica       Date:  2009-10-01       Impact factor: 9.941

Review 8.  Advances and issues in flow cytometric detection of immunophenotypic changes and genomic rearrangements in acute pediatric leukemia.

Authors:  Xin Maggie Wang
Journal:  Transl Pediatr       Date:  2014-04

9.  Poor Prognosis Biomolecular Factors Are Highly Frequent in Childhood Acute Leukemias From Oaxaca, Mexico.

Authors:  Gerardo Juárez-Avendaño; Nuria Citlalli Luna-Silva; Euler Chargoy-Vivaldo; Laura Alicia Juárez-Martínez; Mayra Noemí Martínez-Rangel; Noemí Zárate-Ortiz; Edith Martínez-Valencia; Briceida López-Martínez; Rosana Pelayo; Juan Carlos Balandrán
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

10.  Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth.

Authors:  Xun Ma; Sandy W Wong; Ping Zhou; Chakra P Chaulagain; Parul Doshi; Andreas K Klein; Kellie Sprague; Adin Kugelmass; Denis Toskic; Melissa Warner; Kenneth B Miller; Lisa Lee; Cindy Varga; Raymond L Comenzo
Journal:  Exp Hematol Oncol       Date:  2018-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.